Could a single daily pill deliver Parkinson’s medication?

News

Author: Simge Eva DoganPublished: 1 October 2020

Prep: Cook: Serves:

NTU Assoc Prof Joachim Loo and LiberaTx COO Shashi Kesavapany holding their new drug microcapules in their hands

Scientists at Nanyang Technological University, Singapore, have developed a new pill that could be used to slowly deliver medication over a 24-hour period to people living with Parkinson’s disease.

They hope that delivering Parkinson’s medication in this way could help manage symptoms which can occur when people experience ‘off’ periods between taking medications. A team at the university’s startup LiberaTx is now commercialising the technology and planning clinical trials to test the efficacy of the pill.

Joachim Loo (pictured left), associate professor at the university and founder of LiberaTx, said: “We hope that […] reducing dosage to just once-a-day would greatly improve patient compliance, lower the pill burden of these patients, while alleviating the ‘off’ periods that these patients experience. Achieving this would greatly improve quality of life for the patient.”

If the pill is proven successful for treating Parkinson’s disease, it may also be used for treating other conditions that require taking multiple drugs daily.

Lead image credit: NTU Singapore

Read more about the new pill for delivering Parkinson’s medication here.

For more information on the latest Parkinson’s research please visit the EPDA website.

Has Covid-19 impacted access to Parkinson’s medication?

Last Month

Next Month

Go Back

Share this story

Comments

Resources & Tools

Parkinson’s podcast: DBS – a report from the front lines

Get the low-down on new surgical and non-surgical interventions

Covid-19 and Parkinson’s disease: a lasting impact?

Exploring the link between pandemics, viruses and the condition

“There’s a stigma that if you don’t ‘look sick’ then there is nothing wrong”

Jennifer Parkinson reflects on young-onset Parkinson’s

Ireland survey aims to uncover link between pesticides and Parkinson’s disease

Previous studies of vineyard and agricultural workers in France and the US highlight potential correlations between pesticide exposure and Parkinson’s risk. Now, a team is conducting the first study in Ireland to investigate this potential link. Last week, researchers from University College Cork, Ireland, took to the country’s National Ploughing Championships – a three-day country show, agricultural trade fair and ploughing competition. Their goal? To “gather information on the environmental risks associated with Parkinson’s in Ireland”, according to Professor Aideen Sullivan of the university’s Department of Anatomy and Neuroscience. “Our survey is a broad-stroke approach. We are going to ask people what categories of pesticides they’ve used,” said Sullivan’s colleague, Dr Lucy Collins-Stack. “We are going into this thinking there may be a stronger link with rural settings rather than towns, but we still want to look at both.” The survey can be completed online.

Is there a link between Parkinson’s disease and blood vessel dysfunction?

Scientists in Slovakia have investigated the link between blood vessel dysfunction and Parkinson’s – and found that dopamine agonists may have an impact. The team studied the function of the endothelium – a membrane which lines the heart and blood vessels and helps control blood fluidity – in 41 people with the condition and 41 people without. Endothelial function was then measured through a parameter that assessed how easily blood could flow through the vessels. The results showed that while more people with Parkinson’s had endothelial dysfunction compared to those without, the difference did not reach statistical significance. However, the researchers noted that the findings suggested “an association between smoking, dopamine agonists, and impaired endothelial function” in those with the condition. Outlining the study’s limitations, the team noted that more research is needed to explore this potential link.

New swab test may help with Parkinson’s disease diagnosis

Researchers at the University of Manchester, UK, have drawn on one woman’s sense of smell to develop a swab test that may be used to detect Parkinson’s. The scientists used the test to analyse sebum (a type of oily substance on the skin) in 79 people with Parkinson’s and a control group of 71 healthy individuals. The team identified more than 4,000 different compounds in the participant samples – including 500 that were unique to those living with the condition. The test was developed with the help of Joy Milne from Perth, Scotland, whose unique sense of smell meant that she noticed a change in her late husband Les’s odour twelve years before he was diagnosed with Parkinson’s. Speaking to the BBC, Professor Perdita Barran, who led the research, described the test as potentially “transformative” – and said that the team hopes to roll the test out to people in…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Phone
This field is for validation purposes and should be left unchanged.

Could a single daily pill deliver Parkinson’s medication?

News

Author: Simge Eva DoganPublished: 1 October 2020

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Resources & Tools

Parkinson’s podcast: DBS – a report from the front lines

Global update

Covid-19 and Parkinson’s disease: a lasting impact?

Interviews

“There’s a stigma that if you don’t ‘look sick’ then there is nothing wrong”

Ireland survey aims to uncover link between pesticides and Parkinson’s disease

Is there a link between Parkinson’s disease and blood vessel dysfunction?

New swab test may help with Parkinson’s disease diagnosis

{title}

Subscribe

Could a single daily pill deliver Parkinson’s medication?

News

Author: Simge Eva DoganPublished: 1 October 2020

Last Month

Next Month

Share this story

Comments

Related articles

Resources & Tools

Parkinson’s podcast: DBS – a report from the front lines

Global update

Covid-19 and Parkinson’s disease: a lasting impact?

Interviews

“There’s a stigma that if you don’t ‘look sick’ then there is nothing wrong”

Ireland survey aims to uncover link between pesticides and Parkinson’s disease

Is there a link between Parkinson’s disease and blood vessel dysfunction?

New swab test may help with Parkinson’s disease diagnosis

{title}

Subscribe

Sign in